Research programme: non-coding RNAs targeting small molecule therapeutics - NextRNA Therapeutics
Latest Information Update: 20 Nov 2023
At a glance
- Originator NextRNA Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Long noncoding RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Immunological disorders; Neurological disorders